Professor Kiwon Lee, MD, FACP, FAHA, FCCM is an internationally renowned academic neurointensivist and vascular neurologist. A graduate of Columbia University, he received formal training in stroke, neurological and neurosurgical critical care from Harvard Medical School – Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, Massachusetts. He joined Jefferson Medical College of Thomas Jefferson University, Philadelphia in 2005 and served as the Director of Neuro-Intensive Care Unit and Program Director of the Neuro-Critical Care Fellowship training. He then served as faculty neurointensivist at Columbia University College of Physicians and Surgeons from 2007 to 2012, and trained generations of neurology and neurosurgery residents and fellows. From 2012 to 2017, he became vice chair of neurosurgery for critical care and division chief of neurocritical care at the University of Texas Medical School at Houston and developed the neuroscience and neurotrauma intensive care program as one of the largest programs in the country. Since July 2017, Dr. Lee has been recruited and appointed as Professor of Neurology at Rutgers, the state university of New Jersey, Robert Wood Johnson Medical School, and Chief of Neurology at Robert Wood Johnson University Hospital. Dr. Lee also serves as the director of RWJ comprehensive stroke center, division chief of stroke and critical care, and director of neuroscience intensive care unit. Dr. Lee holds a joint academic appointment in the department of Neurosurgery as full Professor of Neurosurgery, and trains all neurosurgeons in training.
Research Areas:
His research focuses on acute interventional stroke therapies and advanced treatment of delayed ischemic neurological deficits after subarachnoid hemorrhages. He has been actively involved in hemostasis research as well as advanced cardiac output monitoring research for severe brain injury patients. He has multiple clinical research projects in the area of acute ischemic stroke, aneurysmal subarachnoid hemorrhage, severe traumatic brain and spine injuries as well as multimodality neurocritical care monitoring for life-threatening neurological emergencies.
